Free Trial
→ This free guide explains options the way they should be taught (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$266.28
-3.3%		$270.11
$100.02
▼
$452.70
$294.03B3.785.94 million shs4.25 million shs
ArcelorMittal stock logo
MT
ArcelorMittal
$64.05
+4.5%		$72.18
$36.70
▼
$79.68
$47.51B1.541.43 million shs1.31 million shs
Novartis AG stock logo
NVS
Novartis
$143.67
+0.4%		$149.11
$121.57
▼
$170.46
$273.08B0.411.95 million shs1.90 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
-3.27%-13.40%+0.78%-17.66%+59.67%
ArcelorMittal stock logo
MT
ArcelorMittal
+4.41%-0.59%-16.87%-3.13%+56.49%
Novartis AG stock logo
NVS
Novartis
+0.34%+1.92%+4.48%-6.74%+8.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$266.28
-3.3%		$270.11
$100.02
▼
$452.70
$294.03B3.785.94 million shs4.25 million shs
ArcelorMittal stock logo
MT
ArcelorMittal
$64.05
+4.5%		$72.18
$36.70
▼
$79.68
$47.51B1.541.43 million shs1.31 million shs
Novartis AG stock logo
NVS
Novartis
$143.67
+0.4%		$149.11
$121.57
▼
$170.46
$273.08B0.411.95 million shs1.90 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
-3.27%-13.40%+0.78%-17.66%+59.67%
ArcelorMittal stock logo
MT
ArcelorMittal
+4.41%-0.59%-16.87%-3.13%+56.49%
Novartis AG stock logo
NVS
Novartis
+0.34%+1.92%+4.48%-6.74%+8.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
2.70
Moderate Buy$303.3213.91% Upside
ArcelorMittal stock logo
MT
ArcelorMittal
2.55
Moderate Buy$74.5516.39% Upside
Novartis AG stock logo
NVS
Novartis
2.20
Hold$145.601.34% Upside

Current Analyst Ratings Breakdown

Latest MT, ARM, and NVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2026
ArcelorMittal stock logo
MT
ArcelorMittal
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy
10/6/2026
Novartis AG stock logo
NVS
Novartis
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$156.00
10/6/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$69.00 ➝ $64.00
10/5/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$79.00
9/29/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C+) ➝ Hold (C)
9/21/2026
Novartis AG stock logo
NVS
Novartis
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell
9/17/2026
Novartis AG stock logo
NVS
Novartis
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/17/2026
Novartis AG stock logo
NVS
Novartis
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/11/2026
ArcelorMittal stock logo
MT
ArcelorMittal
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
9/11/2026
Novartis AG stock logo
NVS
Novartis
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$147.00 ➝ $130.00
9/10/2026
Novartis AG stock logo
NVS
Novartis
HSBC Holdings plc logo
HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeReduce ➝ Hold$123.00 ➝ $136.00
(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$4.92B57.81$1.07 per share249.65$7.84 per share33.96
ArcelorMittal stock logo
MT
ArcelorMittal
$62.85B0.79$7.93 per share8.08$72.95 per share0.88
Novartis AG stock logo
NVS
Novartis
$54.53B5.03$10.78 per share13.33$22.04 per share6.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$904M$0.97274.52140.158.1620.25%12.24%9.41%11/4/2026 (Estimated)
ArcelorMittal stock logo
MT
ArcelorMittal
$3.15B$2.3627.148.750.512.88%4.20%2.42%11/5/2026 (Estimated)
Novartis AG stock logo
NVS
Novartis
$13.98B$6.6321.6714.662.7323.29%38.56%14.47%10/27/2026 (Estimated)

Latest MT, ARM, and NVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
ArcelorMittal stock logo
MT
ArcelorMittal
$0.85N/AN/AN/A$17.15 billionN/A
11/4/2026Q2 2027
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$0.48N/AN/AN/A$1.38 billionN/A
10/27/2026Q3 2026
Novartis AG stock logo
NVS
Novartis
$2.25N/AN/AN/A$14.59 billionN/A
7/30/2026Q1 2027
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
$0.40$0.45+$0.05$0.25$1.26 billion$1.29 billion
7/30/2026Q2 2026
ArcelorMittal stock logo
MT
ArcelorMittal
$1.18$0.90-$0.28$0.89$17.56 billion$16.76 billion
7/21/2026Q2 2026
Novartis AG stock logo
NVS
Novartis
$2.17$2.41+$0.24$1.71$14.07 billion$14.41 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/AN/AN/AN/AN/A
ArcelorMittal stock logo
MT
ArcelorMittal
$0.510.80%N/A21.61%N/A
Novartis AG stock logo
NVS
Novartis
$3.082.14%+5.28%46.46%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/A
5.25
5.25
ArcelorMittal stock logo
MT
ArcelorMittal
0.21
1.43
0.57
Novartis AG stock logo
NVS
Novartis
0.89
0.86
0.67

Institutional Ownership

CompanyInstitutional Ownership
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
7.53%
ArcelorMittal stock logo
MT
ArcelorMittal
9.29%
Novartis AG stock logo
NVS
Novartis
13.12%

Insider Ownership

CompanyInsider Ownership
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
N/A
ArcelorMittal stock logo
MT
ArcelorMittal
0.06%
Novartis AG stock logo
NVS
Novartis
0.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arm Holdings PLC Sponsored ADR stock logo
ARM
ARM
9,5841.07 billionN/ANot Optionable
ArcelorMittal stock logo
MT
ArcelorMittal
125,554775.00 million774.54 millionOptionable
Novartis AG stock logo
NVS
Novartis
75,2671.91 billion1.91 billionOptionable

Recent News About These Companies

Douglas Lane & Associates LLC Reduces Holdings in Novartis AG $NVS
October 9 at 1:09 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-douglas-lane-associates-llc-reduces-holdings-in-novartis-ag-nvs-2026-10-09/
Novartis Wins FDA Approval For First Symptomatic Dermographism Treatment
October 8 at 5:29 PM  |  rttnews.comhttps://www.rttnews.com/3697471/novartis-wins-fda-approval-for-first-symptomatic-dermographism-treatment.aspx
NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido
October 8 at 1:20 PM  |  zacks.comhttps://www.zacks.com/stock/news/3003077/nvs-wins-fda-nod-for-label-expansion-of-immunology-drug-rhapsido?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-3003077
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
October 8 at 10:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag---nvs-302902146.html
FDA approves Novartis drug Rhapsido for symptomatic dermographism
October 8 at 1:36 AM  |  streetinsider.comhttps://www.streetinsider.com/Corporate+News/FDA+approves+Novartis+drug+Rhapsido+for+symptomatic+dermographism/27160260.html
Novartis AG (NYSE:NVS) Stock Has Average Target Price of $145.60 According to Brokerages
October 7 at 4:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095267
Novartis AG (NYSE:NVS) Stock Has Average Price Target of $145.60
October 7 at 4:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-novartis-ag-nyse-nvs-stock-has-average-price-target-of-14560-2026-10-07/
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
October 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/06/3376062/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag-nvs.html
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
October 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3000454/novartis-strengthens-rna-therapeutics-pipeline-with-7-8b-abogen-deal?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-3000454
Novartis Signs Deal With Abogen For MRNA Therapies
October 2, 2026  |  rttnews.comhttps://www.rttnews.com/3696234/novartis-signs-deal-with-abogen-for-mrna-therapies.aspx
Novartis Signs RNA Therapy Licensing Deal With China’s Abogen Worth Up to $7.8 Billion
October 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/novartis-signs-rna-therapy-licensing-102433389.html
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
October 2, 2026  |  cnbc.comhttps://www.cnbc.com/2026/10/02/novartis-abogen-china-biotech-deal.html
Novartis to License Drug From China's Abogen in Up to $7.8 Billion Deal
October 2, 2026  |  wsj.comhttps://www.wsj.com/health/pharma/novartis-to-license-drug-from-chinas-abogen-in-up-to-7-8-billion-deal-4ad8509c
Novartis signs mRNA deal for about $7.8 billion with China's Abogen
October 2, 2026  |  reuters.comhttps://www.reuters.com/legal/litigation/novartis-strikes-about-78-billion-mrna-deal-with-chinas-abogen-2026-10-02/
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
October 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag---nvs-302895440.html
Novartis Falls as Investors Continue to Digest September Trial Setbacks
September 30, 2026  |  quiverquant.comQ
Novartis AG (NVS) Shares Fall 0.8% -- What GF Score of 78 Tells Investors
September 29, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9102503/novartis-ag-nvs-shares-fall-08-what-gf-score-of-78-tells-investors
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3371428/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag-nvs.html
Zacks Research Weighs in on Novartis' Q1 Earnings (NYSE:NVS)
September 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31063732
Zacks Research Issues Negative Outlook for Novartis Earnings
September 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-zacks-research-issues-negative-outlook-for-novartis-earnings-2026-09-29/
Novartis (NYSE:NVS) Stock Sold by Rep. Kevin Hern
September 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-novartis-nyse-nvs-stock-sold-by-rep-kevin-hern-2026-09-29/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Server hardware in a data center rack featuring a processor chip labeled with the Arm logo.
Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
By Jeffrey Neal Johnson | September 22, 2026
Digital illustration of a glowing central sphere connected to screens, servers, and cloud icons symbolizing cloud computing and data networks.
AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
By Nathan Reiff | September 21, 2026
Three military surveillance drones fly near a mobile radar unit at an airfield during sunset.
3 Defense Stocks Riding the High-Energy Laser Boom
By Nathan Reiff | September 15, 2026
Rows of used vehicles parked in a lot outside a CarMax dealership building with its logo displayed.
CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
By Thomas Hughes | September 29, 2026
Costco Wholesale storefront with shoppers and carts, gas station nearby, and an upward stock chart arrow overlay.
Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
By Jessica Mitacek | September 25, 2026
ARM stock logo

ARM NASDAQ:ARM

$266.28 -9.01 (-3.27%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$265.96 -0.32 (-0.12%)
As of 10/9/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

ArcelorMittal stock logo

ArcelorMittal NYSE:MT

$64.05 +2.75 (+4.49%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$64.12 +0.07 (+0.11%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the United States, Europe, and internationally. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Liberia, Mexico, South Africa, and Ukraine. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.

Novartis stock logo

Novartis NYSE:NVS

$143.67 +0.56 (+0.39%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$143.77 +0.10 (+0.07%)
As of 10/9/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas